Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Homotypic cell membrane-cloaked biomimetic nanocarrier for the accurate photothermal-chemotherapy treatment of recurrent hepatocellular carcinoma

Fig. 2

Validating the homologous targeting ability of HepM-TSL. Fluorescence images of HepG2 cells (a) and L02 cells (b) incubated with ICG-Dox-HepM-TSL, ICG-Dox-TSL nanoparticles and PBS for 4 h. c Quantitative histograms of the Dox fluorescence intensities and ICG fluorescence intensities in (a). d Quantitative histograms of the Dox fluorescence intensities and ICG fluorescence intensities in (b) Scale bar: 75 μm. The concentration of Dox in ICG-Dox-HepM-TSL, ICG-Dox-TSL nanoparticles, free-ICG-DOX were kept the same

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us